Dr Christos Tziotzios specialises in scalp, hair and nail disorders, alongside his general medical dermatology practice (e.g. acne, rosacea, psoriasis, eczema) and skin cancer.
Dr Christos Tziotzios specialises in scalp, hair and nail disorders, alongside his general medical dermatology practice (e.g. acne, rosacea, psoriasis, eczema) and skin cancer.
Alongside his work at Cadogan Clinic, Dr Tziotzios is a Consultant Dermatologist and Honorary Clinical Senior Lecturer at St. John's Institute of Dermatology, Guy's and St. Thomas' Hospitals NHS Foundation Trust, London.
Dr Tziotzios obtained his medical qualifications from the University of Cambridge. He undertook Academic Foundation Training and completed his Core Medicine Training at Cambridge University Hospitals before competitively being appointed Academic Clinical Fellow in Dermatology at St. John’s.
Dr Tziotzios developed an interest in molecular genetic research and hair disorders and secured substantial research grant funding in order to undertake doctoral research into dissecting the molecular pathogenesis of a highly distressing type of scarring hair loss affecting women. His PhD research at St. John’s has culminated in high-impact publications, including an original article in Nature Communications, and several distinctions such as the BAD Whimster Prize, the RSM Research Prize and the NIHR/BAD Award.
He remains active in basic and clinical research: he has recently been awarded the BSF Young Investigator Award and leads a UK-wide research consortium investigating lichenoid, scarring and alopecic disorders. He is also the National (UK) Chief Investigator for the ALLEGRO studies into a novel and promising class of medicines for alopecia areata.
Dr Tziotzios teaches undergraduate and postgraduate (MSc) students and supervises PhD candidates at King’s College London, whilst is regularly invited speaker in local, regional, national and international scientific meetings.
Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 Tziotzios C, et al. Nat Commun 2019. PMID 30850646 Free PMC article.
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa Lwin SM, et al. JCI Insight 2019. Among authors: Tziotzios C. PMID 31167965 Free PMC article.
Nail lichen planus Tziotzios C, et al. J Am Acad Dermatol 2019. PMID 30682393
Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis Tziotzios C, et al. J Am Acad Dermatol 2018 – Review. PMID 30318136
Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies Tziotzios C, et al. J Am Acad Dermatol 2018 – Review. PMID 30318137
Congenital Anonychia and Uncombable Hair Syndrome: Coinheritance of Homozygous Mutations in RSPO4 and PADI3 Hsu CK, et al. J Invest Dermatol 2017. Among authors: Tziotzios C. PMID 28087452 Free article.
Finasteride is of uncertain utility in treating frontal fibrosing alopecia Tziotzios C, et al. J Am Acad Dermatol 2016. PMID 26979373
Frontal fibrosing alopecia: there is no statistically significant association with leave-on facial skin care products and sunscreens Seegobin SD, et al. Br J Dermatol 2016. Among authors: Tziotzios C. PMID 27614082
Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia Tziotzios C, et al. J Invest Dermatol 2017. PMID 28774594 Free article.
Familial frontal fibrosing alopecia Tziotzios C, et al. J Am Acad Dermatol 2015. PMID 26089074
Clinical features and WNT10A mutations in seven unrelated cases of Schöpf-Schulz-Passarge syndrome Tziotzios C, et al. Br J Dermatol 2014. PMID 24902757
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA Lindhurst MJ, et al. Nat Genet 2012. PMID 22729222 Free PMC article. Among authors: Tziotzios C.
Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation Profyris C, et al. J Am Acad Dermatol 2012 – Review. Among authors: Tziotzios C.
Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures Tziotzios C, et al. J Am Acad Dermatol 2012 – Review. PMID 22177632
A true positive nasal nodule Tziotzios C, et al. Am J Med 2012. PMID 22482858
More than just a big thumb Tziotzios C, et al. QJM 2011. PMID 21106503
Swelling scars Tziotzios C and Burden D. QJM 2011. PMID 20400442
Leukemia cutis Tziotzios C and Makrygeorgou A. Cleve Clin J Med 2011. PMID 21460127
There will be a fee for a Consultant-led appointment.
This is representative of the time you spend with the Consultant and the bespoke treatment plan drawn up according to your needs.
Enquire Now
With skin cancer continuing to rise and melanoma being one of the most common types of cancers in young adults, it’s imperative that we continue to check our moles on a regular basis to spot any changes at the earliest stage.
Read more
